"Kettering Cancer Center, located in the Pavilion on Kettering Medical Center's campus is a full-service facilities intended to provide the most advanced patient-centered care in an environment that focuses on healing the whole person—body, mind, and spirit. The Kettering Cancer Care oncology experts and professionals of the Kettering Health will provide you with the most comprehensive, dedicated care in the Miami Valley. With diverse cancer care resources conveniently available throughout the region, no other healthcare provider in the Dayton area offers more far-reaching care."

During the past decade, First Dayton Cancer Care conducted 81 clinical trials. In the 10-year time frame, 81 clinical trials started and 23 clinical trials were completed, i.e. on average, 28.4% percent of trials that started reached the finish line to date. In the past 5 years, 29 clinical trials started and 23 clinical trials were completed. i.e. 79.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "First Dayton Cancer Care" #1 sponsor was "National Cancer Institute (NCI)" with 40 trials, followed by "SWOG Cancer Research Network" with 17 trials sponsored, "Alliance for Clinical Trials in Oncology" with 16 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 11 trials sponsored and "NRG Oncology" with 11 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "First Dayton Cancer Care" #1 collaborator was "National Cancer Institute (NCI)" with 50 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "Astellas Pharma US, Inc." with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "First Dayton Cancer Care" are "Recurrent Lung Non-Small Cell Carcinoma" (5 trials), "Stage IV Lung Cancer AJCC v8" (5 trials), "Lung Non-Squamous Non-Small Cell Carcinoma" (4 trials), "Recurrent Breast Carcinoma" (4 trials) and "Recurrent Ovarian Carcinoma" (4 trials). Many other conditions were trialed in "First Dayton Cancer Care" in a lesser frequency.

Most popular intervention types in "First Dayton Cancer Care" are "Drug" (77 trials), "Other" (49 trials), "Biological" (32 trials), "Procedure" (25 trials) and "Radiation" (5 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (22 trials), "Quality-of-Life Assessment" (19 trials), "Biospecimen Collection" (15 trials), "Computed Tomography" (14 trials) and "Carboplatin" (13 trials). Other intervention names were less common.

The vast majority of trials in "First Dayton Cancer Care" are 77 trials for "All" genders, 10 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "First Dayton Cancer Care". undefined are not yet recruiting, 31 are recruiting, 46 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in First Dayton Cancer Care, 1 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in First Dayton Cancer Care, 1 "Phase 1" clinical trials were conducted, 49 "Phase 2" clinical trials and 39 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".